Aleafia Health Increases Strategic Investment in Australian LP CannaPacific

NEXT STORY
Iterum Therapeutics Presents Data on Risks for Treatment Failure Associated with Uncomplicated Urinary Tract Infection and Activity of its Novel Antibiotic Sulopenem at ECCMID 2019
PREV STORY
FSD Pharma Explores Insurance Coverage for Medical Cannabis in Canada — CFN Media
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Relay & Fio Announce Agreement with Unisys Corp. (NYSE: UIS) to Market a Combined Solution for COVID-19 and Biosecurity Market Needs

author_avatar
NASDAQ Market News

Sunesis Announces Pricing of $20 Million Offering of Securities

SOUTH SAN FRANCISCO, Calif., Oct. 25, 2017 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) ...

author_avatar
NASDAQ Market News

SELLAS Life Sciences Presents Interim Phase 1 Clinical Data of Galinpepimut-S (GPS) in Combination with Nivolumab to Treat Wilms Tumor 1 Positive (WT1+) Ovarian Cancer Patients at ASCO 2018

1-year progression-free survival (PFS) rate of 70% with induction of serum levels of WT1 ...

author_avatar
NASDAQ Market News